The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Longer follow-up on clinical outcomes of weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2 overexpressing metastatic breast cancer.
 
Rui Wang
No Relationships to Disclose
 
Lillian Mary Smyth
Honoraria - AstraZeneca; Pfizer
Consulting or Advisory Role - AstraZeneca; Roche/Genentech
Research Funding - AstraZeneca (Inst); Roche/Genentech (Inst)
Other Relationship - Roche/Genentech
 
Neil M. Iyengar
No Relationships to Disclose
 
Shanu Modi
Speakers' Bureau - Genentech
Research Funding - Daiichi Sankyo; Novartis; Roche/Genentech; Seagen; Synta
 
Sarat Chandarlapaty
Honoraria - Agendia; AstraZeneca; Chugai Pharma; Context Therapeutics; Macrogenics; Novartis; Sermonix Pharmaceuticals
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Macrogenics; Novartis
 
Sujata Patil
No Relationships to Disclose
 
Larry Norton
Stock and Other Ownership Interests - Samus Therapeutics
Honoraria - Bluprint Oncology Concepts; Bluprint Oncology Concepts; Bluprint Oncology Concepts; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Celgene; Celgene; Celgene; Ions Pharmaceuticals; Ions Pharmaceuticals; Ions Pharmaceuticals; Miami Cancer Institute; Miami Cancer Institute; Miami Cancer Institute; Oncolytics; Oncolytics; Oncolytics; Pfizer; Pfizer; Pfizer; Pierian Biosciences; Pierian Biosciences; Pierian Biosciences; Sermonix Pharmaceuticals; Sermonix Pharmaceuticals; Sermonix Pharmaceuticals
Consulting or Advisory Role - Bluprint Oncology Concepts; Bristol-Myers Squibb; Celgene; Ions Pharmaceuticals; Miami Cancer Institute; Oncolytics; Pfizer; Pierian Biosciences; Sermonix Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Bluprint Oncology Concepts; Bristol-Myers Squibb; Celgene; Ions Pharmaceuticals; Miami Cancer Institute; Oncolytics; Pfizer; Pierian Biosciences; Sermonix Pharmaceuticals
Travel, Accommodations, Expenses - Bluprint Oncology Concepts; Bristol-Myers Squibb; Celgene; Ions Pharmaceuticals; Miami Cancer Institute; Oncolytics; Pfizer; Pierian Biosciences; Sermonix Pharmaceuticals
 
Jose Baselga
Leadership - Infinity Pharmaceuticals; Varian Medical Systems
Stock and Other Ownership Interests - GRAIL; Infinity Pharmaceuticals; Juno Therapeutics; PMV Pharma; Varian Medical Systems
Consulting or Advisory Role - GRAIL; Lilly; Novartis
 
Clifford A. Hudis
No Relationships to Disclose
 
Chau T. Dang
Research Funding - Genentech/Roche (Inst); GlaxoSmithKline (Inst)
Travel, Accommodations, Expenses - Genentech